Drebrin is a major F-actin binding protein in dendritic spines that is critically involved in the regulation of dendritic spine morphogenesis, pathology, and plasticity. In this study, we aimed to identify a novel drebrin-binding protein involved in spine morphogenesis and synaptic plasticity. We confirmed the beta subunit of Ca 2+ /calmodulin-dependent protein kinase II (CaMKIIb) as a drebrin-binding protein using a yeast two-hybrid system, and investigated the drebrin-CaMKIIb relationship in dendritic spines using rat hippocampal neurons. Drebrin knockdown resulted in diffuse localization of CaMKIIb in dendrites during the resting state, suggesting that drebrin is involved in the accumulation of CaMKIIb in dendritic spines. Fluorescence recovery after photobleaching analysis showed that drebrin knockdown increased the stable fraction of CaMKIIb, indicating the presence of drebrin-independent, more stable CaMKIIb. NMDA receptor activation also increased the stable fraction in parallel with drebrin exodus from dendritic spines. These findings suggest that CaMKIIb can be classified into distinct pools: CaMKIIb associated with drebrin, CaMKIIb associated with post-synaptic density (PSD), and CaMKIIb free from PSD and drebrin. CaMKIIb appears to be anchored to a protein complex composed of drebrin-binding F-actin during the resting state. NMDA receptor activation releases CaMKIIb from drebrin resulting in CaMKIIb association with PSD. Keywords: drebrin, CaMKIIb, drebrin-binding protein, dendritic spine. Drebrin is a filamentous actin (F-actin)-binding protein consisting of two isoforms, drebrin E and drebrin A (Shirao 1995), which are highly expressed in the brain and are localized mainly in dendritic spines of mature neurons . It has been proposed that drebrin regulates local organization of the actin network and modifies cell morphology (for review, see Shirao et al. 2017) . Overexpression of the neuron-specific isoform drebrin A in mature neurons leads to abnormal enlargement of dendritic spines (Hayashi and Shirao 1999) and augments the amplitude and frequency of glutamatergic mEPSC (Ivanov et al. 2009 ). Knockdown (KD) of drebrin A during neuronal development suppresses the morphological maturation of dendritic spines and accumulation of post-synaptic density (PSD)-95 at dendritic spines (Takahashi et al. 2003) . Furthermore, activation of NMDA receptor (NMDAR) induces the exodus of drebrin from dendritic spines (Mizui et al. 2014) . Dendritic spine morphology is strongly linked to neuropsychiatric disorders, including Alzheimer's disease, Down's syndrome, fragile X syndrome, and autism spectrum disorder (Penzes Received June 30, 2017; revised manuscript received March 14, 2018; accepted April 04, 2018. Address correspondence and reprint requests to Hiroyuki Yamazaki, Department of Neurobiology and Behavior, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan. E-mail: spikar@gunma-u.ac.jp 1 These authors contributed equally to this work.
Drebrin is a filamentous actin (F-actin)-binding protein consisting of two isoforms, drebrin E and drebrin A (Shirao 1995) , which are highly expressed in the brain and are localized mainly in dendritic spines of mature neurons . It has been proposed that drebrin regulates local organization of the actin network and modifies cell morphology (for review, see Shirao et al. 2017) . Overexpression of the neuron-specific isoform drebrin A in mature neurons leads to abnormal enlargement of dendritic spines (Hayashi and Shirao 1999) and augments the amplitude and frequency of glutamatergic mEPSC (Ivanov et al. 2009 ). Knockdown (KD) of drebrin A during neuronal development suppresses the morphological maturation of dendritic spines and accumulation of post-synaptic density (PSD)-95 at dendritic spines (Takahashi et al. 2003) . Furthermore, activation of NMDA receptor (NMDAR) induces the exodus of drebrin from dendritic spines (Mizui et al. 2014) . Dendritic spine morphology is strongly linked to neuropsychiatric disorders, including Alzheimer's disease, Down's syndrome, fragile X syndrome, and autism spectrum disorder (Penzes et al. 2011) , and loss of drebrin in dendritic spines is observed in patients with Alzheimer's disease (Harigaya et al. 1996; Hatanpaa et al. 1999; Counts et al. 2006 ) and Down's syndrome (Shim and Lubec 2002) . This evidence demonstrates a critical role for drebrin in the regulation of dendritic spine morphogenesis, pathology, and plasticity.
Drebrin binds to F-actin in vitro without severing, capping, or nucleating activities (Ishikawa et al. 1994) , and competes with tropomyosin, a-actinin, fascin, and myosin V for actin binding (Ishikawa et al. 1994 (Ishikawa et al. , 2007 Sasaki et al. 1996; Sekino et al. 2007 ). In addition, drebrin binds to the actinmonomer-binding protein and stimulator of actin polymerization, profilin (Mammoto et al. 1998) . These data suggest that drebrin can regulate F-actin organization by interacting with other actin-associated proteins. Aside from F-actin and actinregulators, drebrin also interacts with the synaptic proteins Homer (Shiraishi-Yamaguchi et al. 2009 ) and spikar . Homer regulates dendritic spine morphology in cooperation with Shank (Sala et al. 2001) . Spikar is stabilized in dendritic spines by drebrin and is involved in spine formation . Moreover, drebrin binds to the microtubule tip-tracking protein EB3, which is involved in spine morphology through interaction with p140Cap and cortactin (Jaworski et al. 2009 ). These findings suggest that drebrin acts as a central hub for spine-regulating proteins, in addition to its involvement in actin organization. However, although increasing evidence indicates a pivotal role in synapses, the molecular mechanisms of the drebrin complex have not been fully elucidated.
In this study, we aimed to identify a novel drebrin-binding protein localized in dendritic spines with roles in spine morphogenesis and synaptic plasticity. In the course of screening for drebrin-binding proteins, we isolated beta subunit of Ca 2+ /calmodulin-dependent protein kinase II (CaMKIIb) as a novel drebrin-binding partner. CaMKIIb exists in large quantity in neuron as heteromeric complexes with CaMKIIa. Although CaMKII is known to be a pivotal Ca 2+ transducer in neurons, they function not only as a protein kinase but also as a structural component in dendritic spines (Okamoto et al. 2007) . CaMKIIb binds to and bundles F-actin in neurons, and the interaction between CaMKIIb and F-actin is negatively regulated by synaptic activity (Kim et al. 2015) . When long-term potentiation is induced by Ca 2+ influx, active CaMKIIb is released from F-actin and then translocates into post-synaptic density (PSD). On the other hand, inactive CaMKIIb under basal condition is attached to F-actin and localized in a wide range of a dendritic spine (Lu et al. 2014) . However, an upstream protein governing the localization of CaMKIIb in a dendritic spine is unknown. We supposed that drebrin is a candidate protein that is responsible for spine localization of CaMKIIb at resting state. In this study, we show the change in CaMKIIb localization and dynamics in dendritic spines and shafts in drebrin-knockdown (KD) neurons. The results suggest the existence of both drebrin-dependent and drebrinindependent pools of CaMKIIb in a dendritic spine.
Materials and Methods

Materials
The following materials were used: mouse anti-drebrin monoclonal antibody (clone M2F6, Shirao and Obata 1986 ; from our laboratory; RRID:AB_2532045), mouse anti-CaMKIIb monoclonal antibody (Thermo Fisher Scientific, Waltham, MA, USA; Cat.# 13-9800, RRID:AB_2533045), mouse anti-CaMKIIa monoclonal antibody (Thermo Fisher Scientific; Cat.# MA1-048, RRID:AB_325403), mouse anti-c-Myc monoclonal antibody (Santa Cruz, Santa Cruz, CA, USA; Cat.# sc-40, RRID:AB_627268), mouse anti-b-actin monoclonal antibody (Sigma, St. Louis, MO, USA; Cat.# F3022, RRID:AB_476970), mouse anti-FLAG monoclonal antibody (Sigma; Cat.# F3165, RRID:AB_259529), rat anti-HA monoclonal antibody (Roche, Basel, Switzerland; Cat.# 11867431001, RRID: AB_390919) and EDTA-free protease inhibitor cocktail (Roche; Cat.# 11 873 580 001), anti-rat and anti-mouse Horseradish Peroxidase (HRP)-conjugated IgG (Cappel, West Chester, PA, USA; Cat.# 55770 and # 55550), Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA; Cat. # 11668-027), minimum essential medium (MEM; Thermo Fisher Scientific; Cat. # 1095080), Dulbecco's MEM (Wako, Tokyo, Japan; Cat. # 041-29775) and B-27 supplement (Thermo Fisher Scientific; Cat. # 17504044), and p3XFLAG-CMV-14 vector (Sigma; Cat. # E7908), pACT2 (Clontech, Palo Alto, CA, USA; Cat. # 638822), pEGFP-C1 (Clontech; Cat. # 6084-1), pCMV-Myc (Clontech; Cat. # 631604), and pCMV-HA vectors (Clontech; Cat. # K6003-1). Rabbit antiserum against drebrin was described previously . Other chemicals were purchased from Wako (Tokyo, Japan).
Animals
The study was not pre-registered. Pregnant Wistar rats (fetuses at 13 days of gestation; Strain Crlj:WI, Cat# 2312504, RRID: RGD_2312504) were obtained from Charles River Japan Inc. (Tokyo, Japan). The animals had ad libitum access to food and tap water and were maintained under conditions of controlled temperature (23 AE 1°C) and lighting (light/dark cycle: lights on, 06 : 00; lights off, 18 : 00). All animal experiments were carried out in accordance with the guidelines of the Animal Care and Experimentation Committee of Gunma University, Showa Campus. All efforts were made to minimize the number of animals used and to minimize suffering (protocol #17-024).
DNA constructs
Rat CaMKIIb constructs were generated by PCR using Pfu turbo polymerase (Stratagene, La Jolla, CA, USA; Cat. # 600250). The expression vectors of c-Myc-tagged (QKLISEEDL) full-length rat CaMKIIb (Myc-CaMKIIb) cDNA and c-Myc-tagged full-length rat CaMKIIbe (Myc-CaMKIIbe) cDNA (Okuno et al. 2012) were constructed by subcloning the EcoRI/XhoI fragments into the pCMV-Myc vector. HA-tagged (YPYDVPDYA) full-length rat drebrin A (HA-Drebrin) cDNA was constructed by subcloning an XhoI fragment into the pCMV-HA vector. HA-CaMKIIb 1-280 and 281-542 were constructed by subcloning the EcoRI/BglII fragments into the pCMV-HA vector. The cDNA of enhanced GFP-tagged rat CaMKIIb (GFP-CaMKIIb) cDNA was constructed by subcloning the XhoI/BamHI fragment into the pEGFP-C1 vector. The GFPCaMKIIbe cDNA was constructed by subcloning the XhoI/EcoRI fragment into the pEGFP-C1 vector. The FLAG-tagged (DYKDDDDK) full-length rat drebrin A (Drebrin-FLAG) was constructed by subcloning the BglII/KpnI fragment into the p3XFLAG-CMV-14 vector (Sigma). For RNA interference (RNAi) KD, we used a pSUPERneo+gfp vector (OligoEngine, Seattle, WA, USA; Cat. # VEC-PBS-0002) and pSUPERneo vector (OligoEngine; Cat. # VEC-PBS-0006). The shRNA sequences were: drebrin shRNA#1; sense 5 of drebrin shRNA was confirmed in a previous study (Kato et al. 2012) . The details of CaMKIIb shRNA, non-target negative shRNA, and RNAi-resistant drebrin used in this study have been described in previous papers (CaMKIIb, Okamoto et al. 2007 ; non-target negative shRNA, Okuno et al. 2012; RNAi-resistant drebrin, Yamazaki et al. 2014) . The nucleotide sequences in each construct were verified by DNA sequencing.
Yeast two-hybrid system Saccharomyces cerevisiae transformation and two-hybrid screening were carried out using the Y190 strain (MATa gal4 gal80 his3 trp1-901 ade2-101 ura3-52 leu2-3, -112+URA3::GAL-lacZ, LYS2::GAL (UAS)-HIS3 cyk r ) as previously described . To obtain the constructs for the yeast two-hybrid system, rat drebrin A cDNA (Accession No. X59267) was used as a template. The Nterminal region of rat drebrin (amino acid residues 1-233) was subcloned into the pAS404 vector derived from pAS1 (Sekiguchi et al. 2001) . The bait plasmid pAS404-Dr1-233 was transformed into Y190 cells using the conventional lithium acetate-polyethylene glycol method. Cells were grown on tryptophan minus SD medium (SDÀTrp) and further characterized by testing for protein expression and self-activation of the bait before screening. Large-scale transformation was performed using a rat brain cDNA library constructed in pACT2 vector (Clontech), and cells were grown on a 3-aminotriazole (25 mM) plus SDÀTrp, Leu, and His plate and consequently assayed for activation of the HIS3 gene. For twohybrid binding assay, the 5 0 -untranslated regions of CaMKIIb and
CaMKIIa (Brickey et al. 1990) were subcloned into pACT2 vector.
Cell culture and transfection COS7 monkey kidney epithelial cells (RRID: CVCL_0224) were seeded at a density of 10 6 cells in a 35-mm plastic dish (Falcon, Franklin Lakes, NJ, USA) and grown in Dulbecco's MEM supplemented with 10% fetal bovine serum at 37°C in a 5% CO 2 atmosphere. Cells were allowed to adhere for 12-16 h and then transfected with appropriate plasmids using Lipofectamine 2000 reagent, following the manufacturer's instructions. Low-density cultures of hippocampal neurons were prepared by Banker's methods (Takahashi et al. 2003) . Pregnant Wistar rats were killed by cervical dislocation. Hippocampi were dissected from embryonic 18-day-old Wistar rats, dissociated by trypsin treatment, and triturated through a Pasteur pipette. The rat embryos were not divided by the sex. The neurons were plated at a density of 5000 cells/ cm 2 on coverslips coated with poly-L-lysine in MEM supplemented with 10% fetal bovine serum. After cell attachment, coverslips were transferred into a dish containing a glial monolayer sheet and maintained in serum-free MEM with a B-27 supplement. Cytosine b-D-arabinofuranoside (5 lM) was added to the cultures 4 days after plating to inhibit glial proliferation. Neurons were transfected at 7-8 days in vitro (DIV) using Lipofectamine 2000 reagent, and assayed at 16-17 DIV (KD and FRAP) or 20 DIV (NMDAR activation).
Immunoprecipitation and western blotting
Immunoprecipitation was performed using the ProFound Mammalian Myc Tag IP/Co-IP kit (Pierce, Rockford, IL, USA) according to the manufacturer's instructions. In brief, after 48 h of transfection, COS7 cells were washed three times with ice-cold 25 mM Tris-buffered saline (pH 7.2) and lysed in M-PER buffer (Pierce) containing protease inhibitor cocktail. The cell lysates were centrifuged at 16 000 g for 20 min at 4°C, and supernatants were incubated with immobilized anti-Myc antibody agarose for 12-16 h at 4°C with gentle agitation. The immune complexes were precipitated, washed three times with Tris-buffered saline containing 0.05% Tween-20, and eluted by sample buffer at 95°C. For immunoprecipitation of drebrin and CaMKIIbe or short CaMKIIb fragments, HEK293 cells (RRID: CVCL_0045) were harvested in lysis buffer (150 mM NaCl, 50 mM HEPES pH 7.4, 1% Triton X-100, plus inhibitors) and centrifuged at 16 000 g for 20 min at 4°C. The supernatants were pre-cleared with Protein A/G agarose (Pierce) for 1h at 4°C. The pre-cleared lysates were then incubated for 12-16 h at 4°C with 3 lg anti-FLAG monoclonal antibody. After addition of Protein A/G agarose, the immunoprecipitates were incubated for 1 h at 4°C. The Protein A/G agarose with immunoprecipitates were washed three times with lysis buffer, and eluted by sample buffer at 95°C. Samples were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and the proteins were then transferred onto an Immobilon Transfer Membrane (Millipore, Bedford, MA, USA). After transfer, the membrane was blocked in 10% non-fat milk/phosphate-buffered saline (PBS) and incubated for 12-16 h at 4°C in 3% bovine serum albumin (BSA)/ PBS with the appropriate antibody. After washing in PBS, the membrane was incubated for 1 h at 24°C with the appropriate Horseradish Peroxidase-conjugated IgG in 3% BSA/PBS. Immunopositive signals were visualized with an image analyzer (LAS-3000, Fujifilm, Tokyo, Japan). using ECL detection reagents (GE Healthcare, Piscataway, NJ, USA).
Immunocytochemistry and glutamate treatment
Hippocampal neurons were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.2) and then permeated with 0.1% Triton X-100 in PBS. The cells were then incubated with 3% BSA/ PBS and with appropriate antibodies for 12-16 h at 4°C. After washing with PBS, cells were incubated for 1 h at 24°C in 3% BSA/ PBS with an appropriate fluorescence-labeled anti-IgG antibody. For NMDAR activation, cultured neurons were pre-incubated in Tyrode's solution (119 mM NaCl, 2.5 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 25 mM HEPES pH 7.4, 30 mM glucose) for 10 min, and then treated with glutamate (50 lM)/glycine (10 lM) for 10 min (Shen and Meyer 1999) .
Image analysis and quantification
All experiments were repeated at least three times using three different cultures. Each fluorescent image was obtained using a Zeiss Axioplan microscope (Carl Zeiss, Oberkochen, Germany) with a 639 objective lens (NA, 1.4) and a Photometrics series Cool Snap fx cooled CCD camera (Photometrics, Tucson, AZ, USA). The microscopic images (1300 9 1030 pixels) were captured at a spatial sampling of 106 nm/ pixel. To evaluate the spine:dendrite ratio for each protein (CaMKIIb, CaMKIIbe, CaMKIIa, and drebrin), 8-10 mushroom-type spines were selected from two dendrites of GFP-positive neurons for each condition. The immunofluorescence intensities were measured in circles (0.26 lm 2 ) of the spines and the adjacent dendritic shaft. Line scans were performed in MetaMorph software (Molecular Devices, Sunnyvale, CA, USA). For colocalization analysis, binary images were created in Fiji (Schindelin et al. 2012 ) from manual tracings of the dendritic spines and dendritic shaft (20-30 lm) for each neuron after auto threshold. Manders' colocalization coefficients were determined in Fiji using the Coloc2 plug-in. The samples were coded, and image capture and analysis were done by an experimenter blind to treatment groups. Sample size calculation nor power analysis was conducted to predetermine the size.
FRAP analysis
Cultured neurons were transfected with GFP-CaMKIIb (or GFPCaMKIIbe) alone, GFP-CaMKIIb (or GFP-CaMKIIbe) and drebrin shRNA or negative shRNA at 8 DIV and imaged at 15-16 DIV. The neurons were imaged with a Zeiss LSM510 confocal microscope (Carl Zeiss) and a 409 water-immersion objective lens (NA, 1.2) in Tyrode's solution. The GFP fluorescence in a region of interest was bleached 10 times with a 488-nm laser at 100% output. During fluorescence recovery after photobleaching (FRAP) imaging, the GFP fluorescence was captured before and after photobleaching with 5-s intervals for 300 s for GFP-CaMKIIb and GFP-CaMKIIbe, and 1-s intervals for 120 s for GFP alone. Raw data were quantified using MetaMorph software (Molecular Devices). Background intensity was subtracted from the intensity of the region of interest. The intensity data were normalized to the intensity measured at unbleached spines to correct for fluorescence loss during FRAP imaging. Finally, all intensity data were normalized to the average fluorescence intensity of five scans acquired just before bleaching. The FRAP curve was fitted with KaleidaGraph software (Synergy Software, Reading, PA, USA) to the equation: F(t) = 1ÀfsÀfm 9 exp(Àt/s) derived by Star et al. (2002) , where fs, fm, t and s are the stable fraction, dynamic fraction, time (min) and time constant, respectively.
Statistical analysis
Statistical analyses were performed using SPSS software (SPSS, Chicago, IL, USA) and Statcel3 software (OMS, Tokorozawa, Japan). We used Welch's t-tests or Mann-Whitney U-test for single comparisons and ANOVA followed by Tukey-Kramer or Steel-Dwass post hoc test for multiple comparisons. Bar graphs present means AE SEM. Box plots show the median, interquartile, and range. p values of < 0.05 were considered significant.
Results
Drebrin binds to CaMKIIb
We performed a yeast two-hybrid screen to identify novel binding partners for drebrin. The N-terminal region of drebrin (amino acids 1-233), which is common between drebrin isoforms, was used as bait to screen a rat brain cDNA library (Fig. 1a) . We isolated 89 positive clones, two of which were CaMKIIb gene products. One clone encoded full-length CaMKIIb protein (Fig. 1b, Clone 1) , while the other lacked part of the nucleic acid sequence (Fig. 1b , Clone 2). The clone 2 is identical to CaMKIIb isoform X11 (accession number XP_017454561). These clones had conserved identical sequences in the non-coding regions at the 3 0 and 5 0 ends. However, we did not obtain any clones encoding the alpha subunit of Ca 2+ /calmodulin-dependent protein kinase II (CaMKIIa), which is another major subtype of CaMKII in neurons (Erondu and Kennedy 1985) . To clarify if drebrin could bind to CaMKIIa, we performed a yeast twohybrid assay using both CaMKIIa and CaMKIIb with the N-terminal region of drebrin. CaMKIIb clone 1 showed a positive result in the growth test, but neither CaMKIIa, the 5 0 -untranslated region of CaMKIIb, nor the empty vector gave a positive result (Fig. 1c and d) . These findings indicate that CaMKIIb, but not CaMKIIa, selectively interacts with drebrin.
We then analyzed the interaction between drebrin and CaMKIIb by immunoprecipitation. HA-drebrin and MycCaMKIIb were coexpressed in COS7 cells. In control experiments, only HA-drebrin was expressed in COS7 cells. The supernatants of the cell lysates were immunoprecipitated with anti-Myc antibody and the precipitated proteins were then analyzed by western blotting. The band for HA-drebrin was observed in the immunoprecipitation sample at an equivalent level as that in the input sample (Fig. 1e) . In contrast, the band for HA-drebrin was not detected in the control immunoprecipitation without MycCaMKIIb (Fig. 1e) . A similar set of experiments using Myc-drebrin and HA-CaMKIIb showed that HA-CaMKIIb was immunoprecipitated by anti-Myc beads from a cell lysate containing Myc-drebrin and HA-CaMKIIb (Fig. 1f) . Moreover, we analyzed the drebrin-binding region of CaMKIIb by immunoprecipitation from HEK293 cells transfected with Drebrin-FLAG and HA-CaMKIIb 1-280 or 281-542. Anti-FLAG immunoprecipitations showed that drebrin interacts with CaMKIIb 1-280, but not CaMKIIb 281-542 (Fig. 1g ).
Drebrin colocalizes with CaMKIIb in filopodia and mature dendritic spines Drebrin and CaMKIIb are localized in dendritic spines of mature neurons Shen et al. 1998) . We studied the localization of drebrin and CaMKIIb within dendritic spines/filopodia in developing cultured neurons. Cultured neurons were transfected with GFP and immunolabeled with drebrin and CaMKIIb at two neuronal developmental stages. Drebrin and CaMKIIb colocalized diffusely in dendritic filopodia (Fig. 2a , line scan image of 7 DIV) and at the submembranous region of dendritic shafts in immature neurons, although CaMKIIb was also observed in the center region of dendritic shafts (Fig. 2a) . On the other hand, CaMKIIb colocalized with drebrin in almost all dendritic spines in mature neurons (Fig. 2a) . In a dendritic spine, CaMKIIb was closer to plasma membrane than drebrin (Fig. 2a , line scan image of 21 DIV). Manders' colocalization coefficients confirmed that CaMKIIb was colocalized with drebrin in dendritic filopodia and spines (Fig. 2b) . These suggest that CaMKIIb is partly colocalized with drebrin from an early developmental stage.
Drebrin is responsible for dendritic spine localization of CaMKIIb We showed that drebrin governs synaptic targeting of PSD-95 through clustering F-actin in proto-spine (Takahashi et al. 2003) . Based on the above results, we considered that drebrin may govern spine localization of CaMKIIb. We investigated the hypothesis that CaMKIIb was localized in dendritic spines in a drebrin-dependent manner by measuring the spine:dendrite ratio of CaMKIIb immunofluorescence intensity in drebrin-KD neurons. We transfected cultured neurons with drebrin shRNA, control shRNA, or drebrin shRNA and RNAi-resistant drebrin, and imaged the CaMKIIb immunoreactivity of these neurons (Fig. 3a) . CaMKIIb was localized diffusely in dendrites of drebrin-KD neurons compared with control neurons (Fig. 3b, line scan) . Moreover, the spine:dendrite ratio of CaMKIIb was decreased in drebrin-KD neurons (Fig. 3c) , and this ratio decrease was rescued by coexpression of RNAi-resistant drebrin (Fig. 3c) . Actually, the immunofluorescence intensity was decreased in spines but not in dendritic shafts in drebrin-KD neurons ( Figure S1 ). We also examined CaMKIIa localization in drebrin-KD neurons and found that CaMKIIa was diffusely localized in dendritic shafts (Fig. 3d-f) , consistent with the fact that CaMKIIb forms a holoenzyme with CaMKIIa (Bennett et al. 1983) . Similar results were obtained in neurons treated with latrunculin A, an F-actin-disrupting reagent. Latrunculin A treatment nearly abolished drebrin cluster from dendritic spines ( Figure S2a and b) . In parallel, the immunoreactivity of CaMKIIb were decreased in dendritic spines but not in dendritic shafts ( Figure S2c -e). In contrast, drebrin immunofluorescence intensity was unchanged in CaMKIIb-KD neurons ( Fig. 3g-i) . These results suggest that drebrin contributes to the localization of CaMKIIb in dendritic spines, but not vice versa.
Drebrin knockdown increases the stable fraction of CaMKIIb
We analyzed the drebrin-dependence of CaMKIIb stability in dendritic spines by FRAP analysis of individual dendritic spines (Fig. 4a) . As a control for this analysis, we imaged GFP FRAP from neurons transfected with GFP only ( Figure S3a ). The fluorescence of GFP in dendritic spines recovered rapidly after photobleaching to nearly the prebleaching level ( Figure S3b ), indicating that this protocol hardly damaged dendritic spines. We determined the fluorescence intensities of GFP-CaMKIIb before and after photobleaching and quantified the stable fraction ( Fig. 4b and c) . Unexpectedly, the stable fraction of GFP-CaMKIIb was greater in drebrin-KD compared with control neurons, and this increase was canceled by cotransfection with RNAiresistant drebrin (Fig. 4c) . Since both drebrin and CaMKIIb are F-actin binding proteins, it raises a possibility that the changes in CaMKIIb observed in drebrin-KD neurons are because of changes in F-actin. To test the specificity of drebrin-KD, we analyzed a non-F-actin binding CaMKIIb isoform CaMKIIbe in drebrin-KD neurons. We first confirmed the interaction between CaMKIIbe and drebrin by an immunoprecipitation (Fig. 5a ). This indicates that CaMKIIb binds to drebrin, but not through F-actin. In drebrin-KD neurons, the spine accumulation of Myc-CaMKIIbe was weak compared with that in control neurons ( Fig. 5b and c) . Indeed, the spine:dendrite ratio of Myc-CaMKIIbe was decreased in drebrin-KD neurons (Fig. 5d) . The FRAP analysis of GFP-CaMKIIbe showed similar data to those obtained from GFP-CaMKIIb (Fig. 5e-g ). These results suggest that the CaMKIIb changes in drebrin-KD neurons depend on specific interaction between CaMKIIb and drebrin. Our FRAP data indicate that CaMKIIb was more stable in dendritic spines in the absence of drebrin, suggesting the existence of a pool of more stable CaMKIIb, in addition to drebrin-binding CaMKIIb. To validate this hypothesis, we focused on the fact that NMDAR activation induces CaMKIIb accumulation (Shen and Meyer 1999) and drebrin exodus (Sekino et al. 2006; Mizui et al. 2014) in parallel. Similar to a previous study (Shen and Meyer 1999) , in control neurons, NMDAR activation with 50 lM glutamate with 10 lM glycine (Glu/Gly) for 10 min enhanced spine localization of CaMKIIb (Fig. 6a-c) and decreased spine localization of drebrin (Fig. 6d-f) . In drebrin-KD neurons, NMDAR activation similarly increased CaMKIIb intensity in spines (Fig. 6c, right column) . These indicate that the activity-dependent accumulation of CaMKIIb into spines is not dependent on drebrin.
We further analyzed the stable fraction of synaptic CaMKIIb accumulated by NMDAR activation. Cultured neurons expressing GFP-CaMKIIb were treated with Glu/ Gly, followed by washing for 10 min, photobleaching, and imaging (Fig. 6g) . FRAP analysis showed that NMDAR activation markedly increased the apparent stable fraction of CaMKIIb in control neurons (Fig. 6h and i ) compared with non-activated neurons (Fig. 4c) . Interestingly, the stable fraction after NMDAR activation was slightly but significantly larger in drebrin-KD neurons than control neurons ( Fig. 6h and i) .
Collectively these indicate that NMDAR activation results in the accumulation of drebrin-independent CaMKIIb, which forms a large stable fraction in dendritic spines. This is consistent with an increase in the stable fraction of CaMKIIb in drebrin-KD neurons in the resting state (Fig. 4c) , despite low levels of CaMKIIb in dendritic spines (Fig. 3a-c) . Furthermore, it is suggested that drebrin-dependent and drebrin-independent pools of CaMKIIb are present in dendritic spines, and that synaptic activity regulates the accumulation of drebrin-independent CaMKIIb. Data are presented as means AE SEM (n = 22 neurons for vehicle, n = 29 neurons for Glu/Gly, **p < 0.01, Welch's t-test). (g) FRAP analysis of GFP-CaMKIIb in Glu/Gly-treated neurons. Cultured neurons were transfected with GFP-CaMKIIb + negative shRNA or drebrin shRNA#1, and then treated with Glu/Gly followed by FRAP imaging. (h) FRAP curves of GFP-CaMKIIb. NMDAR activation immobilized CaMKIIb in dendritic spines in each condition. However, the stable fraction of CaMKIIb was slightly larger in drebrin-KD neurons. (i) Quantification of the stable fractions. Box plots show the median, interquartiles, and range (n = 67 spines for negative shRNA and n = 79 spines for drebrin shRNA#1, **p < 0.01, Mann-Whitney U-test).
Discussion
This study provides the first evidence to show that CaMKIIb interacts with drebrin in dendritic spines. Drebrin-silencing caused diffuse localization of CaMKIIb in cultured neurons, suggesting that drebrin acts as a scaffold for CaMKIIb in dendritic spines. We propose that drebrin-dependent stable CaMKIIb is localized in the central area of the spines, because drebrin levels are low in the PSD area compared with the cytoplasmic area (Kobayashi et al. 2007) . CaMKIIa localization in the spines was also impaired in drebrin-KD neurons although CaMKIIa does not bind to drebrin. The mislocalization of CaMKIIa is likely mediated by a decrease in drebrin-dependent CaMKIIb, because CaMKIIb knockout causes mislocalization of CaMKIIa in cultured neurons (Borgesius et al. 2011) . F-actin disruption by latrunculin A treatment also caused diffuse localization of CaMKIIb. Since cluster like drebrin-immunoreactivity was almost abolished in the latrunculin A treated neurons, we consider that the CaMKIIb decrease in dendritic spines is caused by disappearance of drebrin cluster. Interestingly, the latrunculin A treatment did not decrease the immunofluorescence intensity of CaMKIIb in dendritic shafts. This suggests that CaMKIIb localization in dendritic shafts is not dependent on actin cytoskeleton.
Both drebrin (Ishikawa et al. 1994) and CaMKIIb (Shen et al. 1998; Okamoto et al. 2007) bind to F-actin, raising the possibility that these molecules interact with each other via F-actin. Given that one drebrin molecule binds stoichiometrically to five actin molecules (Ishikawa et al. 1994) , more actin than drebrin would thus be expected in the immunoprecipitated complex; however, the present immunoprecipitation experiments showed very little actin in the immunoprecipitate, indicating that CaMKIIb directly interacts with drebrin, rather than indirectly via F-actin. Moreover, our immunoprecipitation data indicate that CaMKIIbe, a non-F-actin binding isoform, can interact with drebrin.
CaMKIIb binds to F-actin, resulting in the stabilization of actin cytoskeleton structure in dendritic spines via preventing the interaction between F-actin and other actin modulating proteins such as cofilin, gelsolin, and Arp2/3 (Kim et al. 2015) . The binding of drebrin to F-actin also stabilizes actin cytoskeleton structure by preventing the interaction between F-actin and other actin modulating proteins, such as cofilin, fascin, and a-actinin. (Ishikawa et al. 1994 ; Sasaki et al. 1996; Grintsevich and Reisler 2014) . This study shows that the N-terminal region of drebrin interacts with the kinase domain of CaMKIIb. These regions do not overlap with the F-actin binding regions of both proteins. This raises a possibility that a tripartite interaction among drebrin, CaMKIIb, and F-actin contributes to the stabilization of actin cytoskeletons. Thus, we propose that the binding of drebrin-CaMKIIb complex to actin cytoskeleton plays a role in the stabilization of dendritic spine under basal condition.
Drebrin has several conserved consensus sites for phosphorylation in its amino acid sequence (Kojima et al. 1993) and is significantly enriched in phosphoaffinity column eluates (Chew et al. 2005) . Mass spectrometry-based analysis has shown that amino acid residues 140-147 of drebrin are phosphorylated in vivo, and one serine residue (Ser 142 ) is a potential CaMKII phosphorylation site (Chew et al. 2005) . Given that the N-terminal sequence of drebrin (amino acids 1-233) used in the present yeast two-hybrid experiment contained this putative phosphorylation site, CaMKIIb may phosphorylate drebrin at Ser 142 after association of these two proteins. Actually, our data showed that drebrin binds to kinase domain of CaMKIIb. Meanwhile, the Ser142 is identified as a phosphorylation site of CDK5 (Worth et al. 2013; Tanabe et al. 2014) . The modification of drebrin Ser142 might thus be regulated temporally and spatially by a number of kinase including CaMKII and CDK5.
CaMKIIb is necessary for maintaining spine structure by bundling of F-actin (Okamoto et al. 2007) . As is the case with CaMKIIb, drebrin is involved in morphological changes in the dendritic spines (Hayashi and Shirao 1999; Mizui et al. 2005; Takahashi et al. 2006) . Drebrin translocates from the spines to the parent dendrite following a Ca 2+ influx through NMDARs, leading to morphological changes (Sekino et al. 2006; Mizui et al. 2014) . This study demonstrated that, while the interaction between drebrin and CaMKIIb was maintained during the resting state in dendritic spines, the interaction was broken by robust Ca 2+ influx from NMDARs, leading to CaMKIIb release from drebrin and accumulation with PSD, where activated CaMKIIb functions as a protein kinase. This is coordinated with previous studies showing that CaMKIIb activation led to a loss of actinbinding activity (O'Leary et al. 2006; Okamoto et al. 2007; Kim et al. 2015) . The interaction between drebrin and CaMKIIb, which may be regulated by Ca 2+ influx via NMDARs, may thus play a pivotal role in morphological synaptic plasticity. Our findings suggest a three-pool model of CaMKIIb in dendritic spines (Fig. 7) . The first pool includes CaMKIIb associated with drebrin, which contributes to CaMKIIb accumulation in dendritic spines during the resting state, but disappears in parallel with the NMDARmediated drebrin exodus in the activated state (Mizui et al. 2014) . In the first pool, CaMKIIb mainly functions as a structural, and can be under standby condition for activation by Ca 2+ influx. We suppose that this pool contributes immediate PSD-translocation for CaMKIIb. The second pool includes CaMKIIb associated with PSD, which forms the major population in dendritic spines during the activated state. FRAP analysis showed that this pool contributes strongly to the increase in the stable fraction of CaMKIIb induced by NMDAR activation, consistent with a recent study showing that CaMKII activated by NMDAR activation is localized at the PSD (Lu et al. 2014) . In the second pool, CaMKIIb is separated from drebrin and would be autophosphorylated. It may function as a protein kinase for several PSD proteins, and is localized in dendritic spines more stable than first pool CaMKIIb. The third pool includes CaMKIIb free from both drebrin and PSD, but which probably binds to F-actin. Because CaMKIIb is not accumulated in dendritic spines of drebrin-KD neurons, this pool may not contribute to the accumulation of CaMKIIb in dendritic spines. CaMKIIb in the third pool would function as a structural protein like the first pool.
In conclusion, we report the relationship between drebrin and CaMKIIb in dendritic spines. CaMKIIb binds to drebrin, and the protein complex is anchored on actin cytoskeleton in core region of a dendritic spine. This interaction is regulated by NMDAR activation. When NMDAR is activated, CaMKIIb is released from drebrin-F-actin complex, which consequently accumulates at PSD.
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